CC
PSTX

Callan Capital’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Callan Capital’s Portfolio PSTX Stock Details PSTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
2024
Q3 		$309K Buy
2024
Q2 		$246K Buy
2024
Q1 		$251K Buy
2023
Q4 		$257K Hold
2023
Q3 		$182K Buy
2023
Q2 		$128K Buy
2023
Q1 		$209K Buy
2022
Q4 		$330K Buy